轻触 发表于 2025-3-23 13:45:50
Bernhard Felderer,Stefan Homburgappropriate postoperative treatments. Nodal status, tumor size, tumor grade, age and HER2 expression are universally accepted as important factors to define risk categories. Newer factors such as uPA/PAI-1, cyclin-E and other proliferative indices and the gene expression profile are promising and wi有害 发表于 2025-3-23 14:38:00
http://reply.papertrans.cn/20/1906/190547/190547_12.pngFELON 发表于 2025-3-23 21:30:33
http://reply.papertrans.cn/20/1906/190547/190547_13.png嬉耍 发表于 2025-3-24 01:38:19
Axillary Lymph Node Status Evaluation in Breast Cancer Patients: Role of SPECT and Pinhole SPECT wisiveness and morbidity. However, ALND may not be necessary in many cases, in particular in early stage carcinomas with tumor size <10 mm and even more so when axillary clinical examination is negative, since in this case the percentage of lymph node metastases is very low. Moreover, even when axillaOFF 发表于 2025-3-24 03:23:15
http://reply.papertrans.cn/20/1906/190547/190547_15.png外貌 发表于 2025-3-24 06:55:46
PET Imaging of Breast Cancer Molecular Biomarkers,h into disease-specific biochemical processes have advanced the development of molecular biomarkers as targets for molecular imaging..A biomarker can be defined as a measurable variable of a molecular, biological or functional process that can also be used as a measure of pharmacologic response to teustachian-tube 发表于 2025-3-24 13:08:47
http://reply.papertrans.cn/20/1906/190547/190547_17.png引起痛苦 发表于 2025-3-24 18:03:15
FDG-PET in Monitoring Therapy of Breast Cancer,onitoring chemotherapy in breast cancer..Whole body imaging with fluorine-18 deoxyglucose PET (FDG-PET) has gained widespread acceptance for the staging and restaging of breast cancer (Biersack et at. 2001; Kostakoglu and Goldsmith 2003; Grahek et al. 2004). Another significant indication for FDG-PE山羊 发表于 2025-3-24 22:27:30
FDG-PET and Tumour Marker Tests for the Diagnosis of Breast Cancer,n screening and early diagnosis; it has an established role in the diagnosis of recurrences; it has an established role in therapy monitoring, alone or in association with other diagnostic tools; it is still under study as a predictor of response to therapy. Several international guidelines help phyConserve 发表于 2025-3-25 02:39:30
Advantages and Limitations of FDG PET 16 in the Follow-Up of Breast Cancer, imaging methods..Limitations of FDG PET in the follow-up of breast cancer patients include the relatively low detection rate of bone metastases, especially in case of sclerotic subtype, and the relatively high rate of false-positive results. The rather low specificity of FDG PET can be improved/inc